Gyma is one of the leading sources for API products and manufacturing. We currently have over 1300 APIs in production and 300 under development or evaluation, covering 205 therapeutic classes. Our APIs have passed rigorous inspections and meet global pharmaceutical guidelines. With our wide selection, we’ve got you covered from A-Z. Below are some of our featured APIs.
Featured APIs
Acalabrutinib
Angiotensin II
Bempedoic Acid
Betadex Sulfobutyl Ether Sodium (SBECD)
Brivaracetam
Brilliant Blue
Cannabidiol
Darolutamide
Dydrogesterone
Elagolix
Etelcalcetide
Ethiodized Oil
Eribulin
Filgotinib
Ibrutinib
Lenvatinib
Methylene Blue
Migalastat
Remdesivir
Relugolix
Rimegepant
Roxadustat
Sacubitril/Valsartan
Safinamide
Semaglutide
Spinosad
Tafamidis
Trabectedin
Trifarotene
Upadacitinib
Vadadustat
Valbeanzine
Venetoclax
Voxelotor
API Services
Crystallization Development
Process Development
Pharmaceutical Solid State Research
Pre-formulation Studies
Polymorph Screening
Polymorphism
As a one-stop-shop, Gyma represents many Contract Manufacturing Organizations, Contract Research Organizations, and Contract Manufacturing and Development Organizations to be the best resource available. We serve as a liaison between you and these different companies, ensuring that you find the right fit to aid your process of development from funding to trials and manufacturing. Simply put, we provide the solutions for you so that your focus can stay on producing the best pharmaceuticals your company has to offer.
With an overwhelming growth of small biotech companies discovering and developing new molecules, the processes may be tricky to navigate. At the core, funding and finding the right partners makes it even harder for certain companies to hold it all together. That’s where Gyma steps in as your partner. We are more than a solution provider, but the focal point to fill your needs with proper dedication. Going above and beyond to make sure you’re connected with the right organizations to get the ball rolling is what we do.
Think of us as your equal partner, here to guide you through your process and make sure it’s as smooth as it should be. As we work with and represent different companies, we help our clients connect with different Contract Manufacturers, Contract Research Organizations, and Contract Manufacturing and Development Organizations depending on what’s needed. From getting assistance with APIs, finished dosage forms, funding, or anything else, we take care of it all. Your success is our main priority, and we are here to help you every step of the way.
We represent a variety of Contract Research Organizations (CROs) who have experience helping US Pharmaceutical companies successfully move a new product from conception to FDA approval. Some of the critical services our CROs provide are product development, commercialization, pre-clinical and clinical research and clinical trials management.
Gyma Laboratories represent a number of Contract Manufacturing Organizations (CMOs) that serve the US market. We will match you with a CMO who can assist you in comprehensive manufacturing services for Finished Dose Formulations such as solid-oral dosages, topicals, injectables and much more.
Does your project require a compound that is hard to find or not yet commercially available on the market? Our Synthesis experts can help you with a wide range of services that are custom-made to fit your specifications. Our expertise and care, ensures pure and structurally-confirmed compounds while maintaining full confidentiality.
Our New Antibody-Drug Conjugates (ADCs)
Ansamitocin P-3 66584-72-3
Maytansinol 57103-68-1
Mertansine (DM1) 139504-50-0
SMCC-DM1 1228105-51-8
MCC-DM1 1228105-53-0
Lys-MCC-DM1 1281816-04-3
DM4 796073-69-3
SPDB-DM4 1626359-62-3
Exatecan 171335-80-1
Dxd 1599440-33-1
Deruxtecan 1599440-13-7
MMAE 474645-27-7
MMAF 745017-94-1
Vc-MMAE 646502-53-6
Vc-MMAF 863971-17-9
MC-MMAF 863971-19-1
Gyma is one of the leading sources for API products and manufacturing. We currently have over 1300 APIs in production and 300 under development or evaluation, covering 205 therapeutic classes. Our APIs have passed rigorous inspections and meet global pharmaceutical guidelines. With our wide selection, we’ve got you covered from A-Z. Below are some of our featured APIs.
Our large network of customers across the US, Europe, India and China gives us the strength and capability to take your products to the global market. Our office locations are strategically located near major pharmaceutical companies and markets. We help you further define and seek the markets were your products are highly sought after and navigate the licensing process.
Gyma offers our clients the ability to enter a Joint Venture partnership where the costs of developing a new product, revenue, assets and expenses can be shared. Like licensing opportunities, products range from generic ANDA, to a 505b2, or an NDA. All projects are carefully screened through a proof of concept stage before being presented to potential partners.
The Gyma team is ready to help your project go from initial ingredient to finished product with ease. If you are looking to purchase an active ingredient or to have your product manufactured, we can get you set up with the delivery, shipping and import resources to get the job done.
